The acquisition of Coldcrete's CO2 utilization technology solidifies CarbonCure's position as the leader in low-carbon and performance-enhancing technology for the concrete sector. “Incorporating Coldcrete’s intellectual property related to CO2 utilization into our portfolio broadens and strengthens our technology offering to customers, and positions us for continued rapid growth in the years ahead,” says CarbonCure’s CEO and Founder Robert Niven.
CarbonCure has commercialized a retrofit CO2 injection technology that allows concrete producers to realize performance benefits such as improved concrete compressive strength and lower mix-to-mix variability, while providing a platform for offering optimized mix designs with a lower carbon footprint. The acquisition of Coldcrete’s CO2 utilization technology enhances CarbonCure's value proposition to its customers and boosts the company's international patent portfolio.
The CO2 utilization technology space continues to gain momentum. Earlier this month CarbonCure announced its participation in the $20 million NRG COSIA Carbon XPRIZE, a global competition to develop breakthrough technologies that convert the most CO2 into products with the highest net value. Co-sponsored by NRG and COSIA, the multi-year competition is designed to address global CO2 emissions from fossil fuels, a leading contributor to climate change.
About CarbonCure Technologies Inc.
CarbonCure is concrete’s gateway to the green building community. Its technology chemically repurposes waste carbon dioxide during the concrete manufacturing process. The company also provides a suite of sales support tools such as customized sales training programs, architectural ride along meetings, and LEED documentation. Through collaboration with leading designers, the company and its partners are supplying a scalable solution to address the growing demand for green building materials. CarbonCure concrete is available through leading concrete manufacturers across North America. Learn more at www.carboncure.com.